English
Take Solutions Q4 Results
- BSE: 532890
- NSE: TAKE
- ISIN: INE142I01023
- Sector: Biotechnology & Drugs
BSE
39.74
-1.27 (-3.10%)
-1.27 (-3.10%)Volume62.57 K
Updated: Wed 21 Jan, 2026 | 14:16:23
NSE
39.70-0.83 (-2.05%)
-0.83 (-2.05%)Volume2.04 M
Updated: Wed 21 Jan, 2026 | 14:07:47
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Take Solutions Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1.15 | 2.90 | -60.44% | 54.51 | -97.89% |
| Depreciation/ Amortization | 0.01 | 0.01 | -9.09% | 0.01 | -23.08% |
| Operating Income | -1.15 | -2.90 | -60.44% | -54.51 | -97.89% |
| Net Income | -4.88 | 47.68 | 0.00% | -,110.61 | -95.59% |
| Other Operating Expenses Total | 1.00 | 2.48 | -59.77% | 15.33 | -93.49% |
| Net Income Before Taxes | 0.30 | 4.90 | -93.79% | -55.04 | 0.00% |
| Total Revenue | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% |
| Selling/ General/ Admin Expenses Total | 0.14 | 0.41 | -65.85% | 0.43 | -67.37% |
| Diluted Normalized EPS | 0.02 | 0.33 | -93.81% | -2.08 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.